Navigation Links
Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL
Date:12/7/2008

round 50%. Even for those who respond to treatment, recurrence of the disease is common.

A growing field of research on the cellular signaling associated with these lymphomas indicates that inhibiting Syk (spleen tyrosine kinase) in aberrant cells may control spread of the disease. Two additional research studies on the topic are also being presented at the ASH meeting. They are: Abstract 377, entitled "BCR, Signaling Diversity in Human Lymphoma B Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes" and Abstract 802, entitled "BCL-6 Regulates Tonic BCR Signaling in Diffuse Large B-Cell Lymphomas." Further information on R788 in B-cell lymphoma is available at Rigel's website: http://www.rigel.com/rigel/lymphoma.

Conference Call and Webcast Information

To access the live call, please dial 800-561-2693 (domestic) or 617-614-3523 (international) 10 minutes prior to the start time and use the passcode 36883961. A replay of the call will be available, in webcast and podcast formats, at approximately 6:00 p.m. PST on December 7, 2008 through December 14, 2008. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the passcode 47095093. The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

About Rigel (http://www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our pion
'/>"/>

SOURCE Rigel
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product
2. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
4. SimQuest Awarded Phase 2 Contract from Office of the Secretary of Defense to Develop Pandemic Influenza Training Program
5. Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077
6. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
7. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
8. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
9. Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
10. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
11. Ceregene Phase 2 Clinical Trial for Alzheimers Disease to be Funded by $5.4 Million Grant From National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Abilene, Texas (PRWEB) September 19, 2014 Yisrayl ... article this week expounding on the need to protect children. ... took place with Michael Brown and reminds that there are ... and victimized. Yisrayl says violence is spreading faster than cancer ... character training. , “There are close to seven billion Michaels ...
(Date:9/18/2014)... (PRWEB) September 19, 2014 Today, Zane ... information on why to switch employees to individual health ... employees may be more familiar with traditional, group health ... that makes employees happier. , The new article ... with individual health insurance rather than group health insurance, ...
(Date:9/18/2014)... WA (PRWEB) September 18, 2014 Kent, ... Lake Meridian Chiropractic are pleased to announce that Dawn Kelly ... 24-year-old clinic. Dr. Saggau looks forward to Ms. Kelly ... and administrative talents will make her a key contributor. ... combination of educational, professional, and personal experiences that will ...
(Date:9/18/2014)... (PRWEB) September 19, 2014 A jacket ... body. A jacket typically has sleeves, and fastens in ... is generally lighter, tighter-fitting, and less insulating than a ... others serve as protective clothing. Today, Fecbek, a well-known ... arrivals of trendy men’s jackets; all these items are ...
(Date:9/18/2014)... 2014 "Medical staff need better ways ... maintaining the patient's privacy," said one of two inventors ... in order to supply caregivers with the equipment they ... a prototype for The Helper to make it easier ... turn patient onto his or her side. It also ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2Health News:Zane Benefits Publishes New Information on Why Employees Are Happier with Individual Health Insurance 2Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Cool Jackets Are For Sale At Fecbek.com 2
... America, Inc., a leading medical diagnostic instrument manufacturer ... of Jim Cusack as Director of Business Development ... of Marketing & Medical Affairs, Sysmex America. ... the company,s existing business partnerships and in identifying ...
... 10 Surfers, cancer survivors and supporters ... Pacific Ocean with a special purpose: to show their support for ... Survivor Beach, they will place their surfboards in the sand, one-by-one, ... surfboards. The line will start at Scripps Pier and continue ...
... Boston University School of Medicine (BUSM) and collaborators have ... ,EUK-400 series, which could someday be used to prevent ... brains of radiological terrorism victims. The findings, which appear ... Biological Inorganic Chemistry , describe new agents which can ...
... "Help is Here Express" bus tour will be stopping in ... various cities in order to help uninsured and financially-struggling Iowans ... or nearly free. With the state,s unemployment rate now hitting ... Partnership for Prescription Assistance (PPA) is ready to help state ...
... 10 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... settlement of the legal proceedings related to Lexapro(R) (escitalopram ... with Forest Laboratories, Inc. ("Forest") to acquire several products ... litigation settlement resolves litigation involving Caraco, Forest, Forest Holdings, ...
... today that the U.S. Food and Drug Administration (FDA) ... industry,s first programmable bone conduction hearing solution. The Baha ... adults with conductive hearing loss, mixed hearing loss or ... BP100 improves upon previous systems by offering users the ...
Cached Medicine News:Health News:Sysmex America Names Industry Veteran to Business Development Post 2Health News:Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9 2Health News:Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9 3Health News:New oral agents may prevent injury after radiation exposure 2Health News:Partnership for Prescription Assistance Prepared to Help Iowa Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Iowa Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Iowa Workers Hurt by Recession 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation 2Health News:Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industry's First Programmable Bone Conduction Hearing Solution 2Health News:Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industry's First Programmable Bone Conduction Hearing Solution 3
(Date:9/18/2014)... , Sept. 18, 2014  Neurotrope, Inc. (OTCQB: NTRP) ... , M.D., Ph.D. to the Company,s Board of Directors, ... fills a vacancy on the Board of seven members. ... and Corporate Governance Committee and a member of the ... a member of Neurotrope,s Scientific Advisory Board, a position ...
(Date:9/18/2014)... , September 18, 2014 After ... chain community, we,re finally here - the new programme for ... January 2015, part of our global Cool Chain series, has ... here ! As the lines between supply ... put together a programme that is broad and yet specific, ...
(Date:9/18/2014)... Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage ... pain, announced today that it has appointed Mr. ... Director of Clinical Development. During his extensive ... led successful global clinical operations teams, in the US ... clinical development of numerous therapeutics and diagnostics across a ...
Breaking Medicine Technology:Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 2Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 4Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2
... 2011 Nationally-acclaimed researcher and award-winning author Dr. Cynthia ... National Conference on Cancer Nursing Research that silver treated ... were supposed to prevent. After testing ... with silver coated or silver impregnated fluid pathway components, ...
... Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced the ... shares of its common stock, offered at a price to ... Optimer from this offering are expected to be $67.5 million, ... offering expenses payable by Optimer.  The offering is expected to ...
Cached Medicine Technology:Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research 2Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock 2Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock 3
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... Antigen-Antibody Pens-Using a proprietary and patented technology, ... pens, called Antigen-Antibody pens-TM, that will allow ... membranes in any form or shape or ... helps to see antigen being written on ...
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... 350 Liters of pure water, Complete, Compact ... Purified Water,Millipores compact S.D.S. Storage and Distribution ... 350 liters of purified water produced by ... consistent purity of stored water, provide effective ...
Medicine Products: